CD8A and neoplasm: identified 11 human-associated bacterial strains that collectively demonstrated effectiveness in stimulating IFNγ+ CD8 T cells, enhancing resistance to the intracellular pathogen Listeria, and inhibiting tumor growth in conjunction with immune checkpoint inhibitors (ICIs).